Sam Brusco, Associate Editor10.10.23
Philips signed a two-year partnership with the World Stroke Organization (WSO) with the goal of broadening access to high-quality stroke care.
The duo said they will leverage their strengths to raise public understanding of stroke as a global health issue, beginning with joint initiatives on World Stroke Day 2023 (October 29) to build better public awareness. The two will also collaborate to support implementation of innovative stroke treatment methods and reduce time between onset of symptoms and effective treatment.
Specifically, the pair said they will drive advocacy and policy based on the latest clinical research and treatment guidelines to inform government departments and healthcare providers about the newest developments in stroke treatment.
“WSO is committed to accelerating the global implementation of evidence-based treatment and care for stroke patients globally,” WSO’s president professor Sheila Martins told the press. “We know what works and we know that it takes every part of the healthcare system, working together to bring quality care to every patient.”
Philips’ technology portfolio for stroke diagnosis and treatment includes solutions for stroke monitoring and communication in ambulances, tele-stroke patient assessment, artificial intelligence (AI) supporting diagnostic imaging and analysis, image-guided therapy, and neurological and cardiac monitoring and assessment.
The company also makes fully integrated angio suite systems that aim to facilitate mechanical thrombectomy. This procedure is often performed to minimize brain tissue damage and improve chance of recovery following a stroke.
“Both innovation and public awareness are essential to improve time-to-treatment and access to care for patients suffering a stroke,” said Philips’ chief medical officer of Image Guided Therapay Dr. Atul Gupta. “Working closely with WSO, we can further shape the future of neurovascular interventions and help provide groundbreaking and effective high-quality care to patients so they can resume normal life after a stroke.”
The duo said they will leverage their strengths to raise public understanding of stroke as a global health issue, beginning with joint initiatives on World Stroke Day 2023 (October 29) to build better public awareness. The two will also collaborate to support implementation of innovative stroke treatment methods and reduce time between onset of symptoms and effective treatment.
Specifically, the pair said they will drive advocacy and policy based on the latest clinical research and treatment guidelines to inform government departments and healthcare providers about the newest developments in stroke treatment.
“WSO is committed to accelerating the global implementation of evidence-based treatment and care for stroke patients globally,” WSO’s president professor Sheila Martins told the press. “We know what works and we know that it takes every part of the healthcare system, working together to bring quality care to every patient.”
Philips’ technology portfolio for stroke diagnosis and treatment includes solutions for stroke monitoring and communication in ambulances, tele-stroke patient assessment, artificial intelligence (AI) supporting diagnostic imaging and analysis, image-guided therapy, and neurological and cardiac monitoring and assessment.
The company also makes fully integrated angio suite systems that aim to facilitate mechanical thrombectomy. This procedure is often performed to minimize brain tissue damage and improve chance of recovery following a stroke.
“Both innovation and public awareness are essential to improve time-to-treatment and access to care for patients suffering a stroke,” said Philips’ chief medical officer of Image Guided Therapay Dr. Atul Gupta. “Working closely with WSO, we can further shape the future of neurovascular interventions and help provide groundbreaking and effective high-quality care to patients so they can resume normal life after a stroke.”